Company eyes vacant Gastonia building for 701-job, $268M project
6 Articles
6 Articles
Company eyes vacant Gastonia building for 701-job, $268M project
Gastonia approved new incentives for Project Nexus, a manufacturing proposal that could bring 701 jobs and a $268M investment to Trinity Capital’s Delta Industrial Park. The building has been vacant since 2023. A decision is expected by June.
Pharmaceutical company to build manufacturing facility in NC
Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, 700,000 square-foot manufacturing facility in Holly Springs, a city in the Research Triangle area. The announcement was made at the company’s DC headquarters by CEO Ashley Magargee, following approval by the North Carolina Department of Commerce’s Economic Investment Committee. This will be Genentech’s first footprint in North …
Swiss giant Roche bets on China with $283M biopharma facility
Swiss pharmaceutical giant Roche announced today that it plans to invest 2.04 billion yuan (about $283M) in building a new biopharmaceutical manufacturing plant in Shanghai's Pudong district. The factory, which will cover 35,300 square meters in the Zhangjiang Technology Park, will focus on producing Vabysmo, a bispecific antibody used to treat eye diseases. China has struggled for years with limited access to advanced medical therapies, leavin…
Roche, Genentech to Develop $700M Pharmaceutical Manufacturing Facility in Holly Springs, North Carolina
HOLLY SPRINGS, N.C. — Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles southwest of Raleigh. The new 700,000-square-foot facility will create 400 high-wage manufacturing jobs and 1,500 construction jobs. The new facility will support Roche and Genentech’s portfolio of next-generation obesity medi…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage